Kevin Pollack, See Remarks at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 4,820 shares at $6.98 ($34K) on 2017-01-13, disclosed to the SEC on 2017-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MNGA | BUY | 2016-12-06 | $20K | — | Filing → |
| PBIO | BUY | 2013-09-04 | $2K | — | Filing → |
| PBIO | BUY | 2013-08-23 | $3K | — | Filing → |